Sandu Pharmaceuticals Reports Name Change of Independent Director Dr Neeti Gupta
Sandu Pharmaceuticals Ltd 路 Others (Uncategorized) 路 09 Oct 2026, 5:10 pm
Sandu Pharmaceuticals Reports Name Change of Independent Director Dr Neeti Gupta Sandu Pharmaceuticals Limited has informed exchanges under Regulation 30 of SEBI LODR that Non-Executive Independent Director Dr Neeti Madan Kapre (DIN: 06801264) has changed her name to Dr Neeti Gupta consequent upon her marriage, as of 9th Oct'26. The company confirmed there are no changes to her designation, directorship, or DIN.
Original exchange filing (PDF)
More announcements from Sandu Pharmaceuticals Ltd
- statement of deviation and variation of funds for q ended 30th sept 2026 路 15 Nov 2026
- Results for Q and half year ended 30th sept 2026 路 15 Nov 2026
- Outcome of the Board Meeting dated 14th November 2026 路 15 Nov 2026
- Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Approval of Unaudited .... 路 14 Nov 2026
- Intimation to the holders of Physical Securities to furnish PAN and KYC details 路 30 Sept 2026
- 1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director 路 12 Sept 2026
- Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting 路 12 Sept 2026
- 41st Annual General Meeting scrutinizers Report 路 12 Sept 2026
